DEM BioPharma Funding: $70M Raised, Series A (2022)

DEM BioPharma is based in Cambridge, MA. It has raised $70M in total funding. Latest round: Series A.

DEM BioPharma funding overview

DEM BioPharma is based in Cambridge, MA. DEM BioPharma has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2022. The round record for DEM BioPharma runs through 2022; nothing later has been disclosed. Investors on record include Longwood Fund, Emerson Collective, Pfizer Ventures, Astellas, 4BIO Capital, Adjuvant Capital and 10 others. 16 distinct backers are named across the disclosed rounds.

DEM BioPharma at a glance

Total raised
$70M
Latest round
Series A
Latest round date
June 2022
Headquarters
Cambridge, MA
Notable investors
Longwood Fund, Emerson Collective, Pfizer Ventures, Astellas, 4BIO Capital, Adjuvant Capital, Agent Capital, Alta Partners

Frequently asked about DEM BioPharma funding

How much has DEM BioPharma raised?
DEM BioPharma has raised $70M in total disclosed funding across the rounds on record.
Who has invested in DEM BioPharma?
Longwood Fund, Emerson Collective, Pfizer Ventures, Astellas, 4BIO Capital, Adjuvant Capital are named among the investors backing DEM BioPharma.
What was the latest DEM BioPharma funding round?
The most recent disclosed round is a Series A, announced in June 2022.
Where is DEM BioPharma based?
DEM BioPharma is based in Cambridge, MA.
When did DEM BioPharma last raise?
The last disclosed DEM BioPharma round closed in June 2022 at Series A.

Every DEM BioPharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.

Companies related to DEM BioPharma (36)

Browse related funding lists (10)

Company funding database · Investor directory · Founder database · Mega-rounds 2026